These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Quantitative risk assessment for developmental neurotoxic effects. Razzaghi M; Kodell R Risk Anal; 2004 Dec; 24(6):1673-81. PubMed ID: 15660620 [TBL] [Abstract][Full Text] [Related]
8. Towards quantitative risk assessment for neurotoxicity. Wyzga RE Neurotoxicology; 1990; 11(2):199-207. PubMed ID: 2234541 [TBL] [Abstract][Full Text] [Related]
9. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Dorman DC; Allen SL; Byczkowski JZ; Claudio L; Fisher JE; Fisher JW; Harry GJ; Li AA; Makris SL; Padilla S; Sultatos LG; Mileson BE Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):101-11. PubMed ID: 11250810 [TBL] [Abstract][Full Text] [Related]
10. An approach to risk assessment. Simonsen L; Lund SP; Hass U Neurotoxicology; 1996; 17(3-4):815-24. PubMed ID: 9086505 [TBL] [Abstract][Full Text] [Related]
11. Unmasking silent neurotoxicity following developmental exposure to environmental toxicants. Kraft AD; Aschner M; Cory-Slechta DA; Bilbo SD; Caudle WM; Makris SL Neurotoxicol Teratol; 2016; 55():38-44. PubMed ID: 27049787 [TBL] [Abstract][Full Text] [Related]
12. Evolution and current status of neurotoxicity risk assessment. Tilson HA Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593 [TBL] [Abstract][Full Text] [Related]
13. Risk management frameworks for human health and environmental risks. Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953 [TBL] [Abstract][Full Text] [Related]
14. In vitro techniques for the assessment of neurotoxicity. Harry GJ; Billingsley M; Bruinink A; Campbell IL; Classen W; Dorman DC; Galli C; Ray D; Smith RA; Tilson HA Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):131-58. PubMed ID: 9539010 [TBL] [Abstract][Full Text] [Related]
15. The role of developmental neurotoxicology studies in risk assessment. Tilson HA Toxicol Pathol; 2000; 28(1):149-56. PubMed ID: 10669002 [TBL] [Abstract][Full Text] [Related]
17. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment. Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757 [TBL] [Abstract][Full Text] [Related]
18. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons. Evangelista de Duffard AM; Duffard R Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):353-60. PubMed ID: 9182042 [TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research. Kimmel CA Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591 [TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity testing: a discussion of in vitro alternatives. Costa LG Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):505-10. PubMed ID: 9599699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]